NABI BIOPHARMA (NASDAQ:NABI)
4.90
+0.22 (4.70%)
| NABI BIOPHARMA (NASDAQ:NABI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $4.68 | 52 Week High | $5.30 | ||
| Open | $4.65 | 52 Week Low | $2.15 | ||
| Day High | $5.00 | P/E | N/A | ||
| Day Low | $4.57 | EPS | $-0.40 | ||
| Volume | 517,047 | ||||
| More NABI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| GSK | 3 | CRXX | 3 |
| PARD | 3 | SPEX | 3 |
| NLST | 2 | FBN | 2 |
| UAUA | 2 | XJT | 2 |
| ADY | 2 | CAEI | 2 |
| ALKS | 2 | AMS | 1 |
Entities who have mentioned NABI
- Merriman Curhan Ford | View Related Stories »
- Third Point LLC | View Related Stories »
- Daniel Loeb | View Related Stories »
- GLG Partners | View Related Stories »
- Greenlight Capital | View Related Stories »
- David Einhorn | View Related Stories »
- Nelson Peltz | View Related Stories »
- Trian Fund | View Related Stories »
- CIBC | View Related Stories »
- Citi | View Related Stories »
- Merrill Lynch | View Related Stories »
- Hedge Funds | View Related Stories »
- Carl Icahn | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Credit Suisse | View Related Stories »
- B. Riley | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- FDIC | View Related Stories »
- Needham & Co | View Related Stories »
- Banc of America | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
View All Major News StreetInsider.com Major News for NABI
- Nabi Biopharmaceuticals (NABI) Tops Q3 EPS by 2c
- Nabi Biopharmaceuticals (NABI) Misses Q1 View By 8c
- Nabi Biopharma (NABI) Reports Q4 Loss of $0.03, Beats by 5c
View All ReportsStreetInsider.com Reports on NABI
- Unusual 11 Mid-Day Movers 11/16: SPEX, NLST, DRAM, XJT Higher; PARD, CRXX, CAEI, CHIO Lower
- Morning Movers 11/16: SPEX, NLST, XJT, NABI, KHD, IBKC, SPA Higher; PARD, CRXX, CAEI Lower
- Biotech Movers: SPEX, NABI, ALKS Up; PARD, CRXX Down
- GLAXO (GSK) and Nabi BioPharma (NABI) Announce Option and Licensing Agreement for NicVAX
- Nabi Biopharmaceuticals (NABI) Tops Q3 EPS by 2c
View All Press ReleasesCompany Press Releases on NABI
- Nabi Biopharmaceuticals to Hold Conference Call
- GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
- Nabi Biopharmaceuticals Announces Third Quarter 2009 Financial Results
- Nabi Biopharmaceuticals Completes Sale of PentaStaph(TM) to GlaxoSmithKline PLC
- Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim
StreetInsider Reports on NABI by Category
View All BlogsBlogs on NABI
- Tuesday's Big Gainers on Heavy Volume
- 37 Breakout Stocks on Big Volume, November 16, 2009
- Nabi Biopharmaceuticals Q3 2009 Earnings Call Transcript
- Biotech Discounts Galore
- 24 Breakout Stocks on Big Volume
View All FilingsSEC Filings on NABI
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 17 Filed by: Aryeh Jason
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 17 Filed by: LYNCH TIMOTHY P
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 16 Filed by: Kalnik Matthew W.
- Form 4 NABI BIOPHARMACEUTICALS For: Nov 16 Filed by: Aryeh Jason
- Form 8-K NABI BIOPHARMACEUTICALS For: Nov 16
Comments on recent NABI articles
Comments on NABI
No comments are currently available.
on Mar 27, 2008
at 09:06 PM Lousy Reporting His departure is part of the recent Biotest deal in which Nabi sold all of it's South Florida assets and anchored the remaining (downsized) staff up north.
Article: Nabi Pharmaceuticals (NABI) CFO Resigns